1000 Patienten mit mäßigem bis sehr schwerem idiopathischen Restless Legs Syndrom untersucht. ###>The efficacy of MIRAPEXIN was evaluated in four placebo-controlled clinical trials in approximately 1000 patients with moderate to very severe idiopathic Restless Legs Syndrome.